Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck

Name: Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Published: 2004
License: Public Domain

Radiation Therapy Oncology Group · 2004

ClinicalTrials.gov · Datasets · License: Public Domain · 2004

Open Source ↗

head-and-neck-cancer

head and neck cancer, stage iii squamous cell carcinoma of the hypopharynx, stage iv squamous cell carcinoma of the hypopharynx, stage iii squamous cell carcinoma of the oropharynx, stage iv squamous cell carcinoma of the oropharynx, stage iii squamous cell carcinoma of the larynx, stage iv squamous cell carcinoma of the larynx, stage iii lymphoepithelioma of the oropharynx, stage iv lymphoepithelioma of the oropharynx, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck

Related documents